Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Sickle Cells Show Potential to… >
Sickle Cells Show Potential to Attack Aggressive Cancer Tumors

Published: January 9, 2013.
By Duke University Medical Center
http://www.dukemednews.org

DURHAM, N.C. – By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.

Reporting in the Jan. 9, 2013, edition of the on-line journal, PLOS ONE, the researchers describe a process of exploiting sickle-shaped red blood cells to selectively target oxygen deprived cancer tumors in mice and block the blood vessels that surround them.

"Sickle cells appear to be a potent way to attack hypoxic (oxygen-starved) solid tumors, which are notable for their resistance to existing cancer chemotherapy agents and radiation," said senior author Mark W. Dewhirst, DVM, PhD, a radiation oncologist and director of Duke's Tumor Microcirculation Laboratory. "This is an exciting finding that suggests a potential new approach to fighting tumors that are currently associated with aggressive disease."

"The very qualities that make sickle cells a danger to people with the inherited genetic disorder can be turned against tumors to fight cancer," said lead author David S. Terman, M.D., head of Molecular Genetics at Jenomic. "Our approach using sickle cells is a novel strategy with broad therapeutic potential that could be directed at breast cancers, prostate cancers, and many other solid tumors that develop resistance to current therapies."

Sickle cells are typically associated with a potentially life-threatening disease in which red blood cells are deformed in the shape of a crescent moon or sickle. Unlike healthy red blood cells that flow smoothly through vessels, the sickle cells get stuck, causing blockages that are painful and damaging to tissue.

A collaborative effort between Duke researchers and scientists from Jenomic began in 2006 to explore whether sickle cells could similarly build clots in the vast networks of blood vessels that feed oxygen-starved, or hypoxic, cancer tumors, which can grow increasingly lethal as their oxygen needs escalate.

In a National Institutes of Health-funded study of mice with breast cancer, the researchers gave the animals an infusion of fluorescently dyed sickle cells and viewed them under special window chambers that provide real-time observation of processes inside the body. Within five minutes, the deformed cells began to adhere to the blood vessels surrounding the hypoxic tumors. Over 30 minutes, the cells had formed clots and began blocking the small blood vessels that fed the tumor.

Dewhirst said the sickle cells stick like Velcro to the hypoxic tumor because it produces an abundance of adhesion molecules as part of its distress from oxygen deprivation. Normal cells don't produce the adhesion molecules, so there's nothing for the sickle cells to snag onto.

"Unlike normal red blood cells, we found that sickle cells show a highly unique natural attraction to oxygen deprived tumors where they stick, cluster and plug tumor blood vessels. Once clustered within the tumor, the sickle cells deposit a toxic iron residue as they die, causing tumor cell death," Terman said.

To boost that caustic effect, the researchers added zinc compounds (zinc protoporphyrin alone or in combination with doxorubicin) to the sickle cells, which caused even greater oxidative stress in the tumor and surrounding blood vessels. This resulted in a dramatic delay in tumor growth, quadrupling the amount of time the tumors were inactive compared to tumors exposed to regular blood cells. Mice showed no acute toxicity to the sickle cell treatment.

"In contrast to drug treatments directed only to the hypoxic tumor cell, our approach uses the inherent qualities of sickle cells to induce injury to the tumor and the vascular micro-environment that feeds the tumor," Terman said.

Dewhirst and Terman said the research team would continue to conduct studies in animals before moving to human trials.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Tumor 
2/13/13 
Key Molecule Suppresses Growth of Cancerous Liver Tumors, Mayo Study Finds
By Mayo Clinic
ROCHESTER, Minn. -- A molecule already implicated in a number of diverse cellular functions can suppress the growth of tumors in the liver, a Mayo Clinic Cancer Center study …
Primary 
12/1/10 
Tumors Bring Their Own Support Cells When Forming Metastases
By Massachusetts General Hospital
The process of metastasis requires that cancer cells traveling from a primary tumor find a hospitable environment in which to implant themselves and grow. A new study from Massachusetts …
Normal 
3/14/10 
New Cancer Drug Screening Technique More Closely Mirrors Reality
By Dana-Farber Cancer Institute
BOSTON –––Improving on traditional screening tests for potential anti-cancer drugs, scientists at Dana-Farber Cancer Institute have developed a laboratory technique that more closely simulates the real-world conditions in which …
Fluid 
7/25/12 

How the Fluid Between Cells Affects Tumors
By The Journal of Visualized Experiments
Protein 
9/28/10 
Nanotechnology Brings Personalized Therapy 1 Step Closer to Reality
By American Association for Cancer Research
DENVER — A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work. …
Tumor 
5/28/10 
Circulating Tumor Cells Correlate with Poorer Survival in Pancreatic Cancer Patients
By Fox Chase Cancer Center
CHICAGO, IL. (May 28, 2010)––Fox Chase Cancer Center investigators find that pancreatic cancer patients who have circulating tumor cells tend to have worse outcomes than patients without circulating tumor …
Percent 
6/15/11 
Low-carbohydrate, High-protein Diets May Reduce Both Tumor Growth Rates And Cancer Risk
By American Association for Cancer Research
PHILADELPHIA — Eating a low-carbohydrate, high-protein diet may reduce the risk of cancer and slow the growth of tumors already present, according to a study published in Cancer Research, …
Cells 
10/28/13 
Mount Sinai Researchers Identify Mechanisms And Potential Biomarkers of Tumor Cell Dormancy
By The Mount Sinai Hospital / Mount Sinai School of Medicine
Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body – so-called disseminated tumor cells – are quick to …
Cancer 
11/15/11 
Uncovering a Key Player in Metastasis: Researchers Determine How Platelets in the Bloodstream Help Cancer Cells Form New Tumors
By Massachusetts Institute of Technology
About 90 percent of cancer deaths are caused by secondary tumors, known as metastases, which spread from the original tumor site. To become mobile and break free from …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition